Abstracts tagged "coronary artery disease"

Abstract Number: 103 • 2020 Pediatric Rheumatology Symposium
Unexpectedly High Incidence of Kawasaki Disease in a Well-Characterized Population in Atlantic Canada
Abdulrahman Alkanhal¹, Joseph , Saunders ², Fajer Altammar ³, Adam Huber ⁴, Andrew Lynk ², Alison MacLeod ⁵, Oliva Ortiz-Alvarez ⁶, Meighan Adams ², Suzanne Ramsey ⁷, Elizabeth Stringer ⁷, Andrew Warren ² and Bianca Lang ⁸, ¹University of Alberta, Edmonton, Alberta, Canada, ²Dalhousie University, Halifax, Canada, ³Mcmaster University, Hamilton, Canada, ⁴IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada, ⁵Annapolis Valley Health, Kentville, Canada, ⁶St Martha's Regional Hospital, Antigonish, Canada, ⁷IWK Health Centre, Halifax, Canada, ⁸Dalhousie University - Halifax, Halifax, Canada
Background/Purpose: Kawasaki Disease (KD), a systemic vasculitis of unknown etiology, is now the leading cause of acquired heart disease in children in North America. Its…
Abstract Number: 366 • 2019 ACR/ARP Annual Meeting
Serum Uric Acid Level and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals: An Observational Cohort Study
Doo-Ho Lim¹, Gyung-Min Park ², Seung Won Choi ³, Su Jin Choi ⁴, So Hye Nam ⁵, Seokchan Hong ⁴, Yong-Gil Kim ⁴, Chang-Keun Lee ⁴ and Bin Yoo ⁴, ¹Division of Rheumatology, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea, ²Ulsan University hospital, Ulsan, Republic of Korea, ³Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Ulsan, Republic of Korea, ⁴Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, ⁵Asan Medical Center, Seoul, Republic of Korea
Background/Purpose: High serum uric acid (SUA) level is the main prerequisite for gout, and it might be associated with obesity, hypertension, glucose intolerance, insulin resistance,…
Abstract Number: 1165 • 2019 ACR/ARP Annual Meeting
Utility of Coronary Calcium Scoring (CCS) in the Spectrum of Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis – a Systematic Review
Sohail Farshad¹, Alexandra Halalau ², Whitney Townsend ³ and Elena Schiopu ⁴, ¹Department of Internal Medicine, Beaumont Health System, Royal Oak, MI, ²Department of Internal Medicine, Beaumont Health System, Royal Oak, ³University of Michigan, Ann Arbor, ⁴Department of Rheumatology, University of Michigan, Ann Arbor
Background/Purpose: Recent literature shows that connective tissue disorders (CTDs) are positively associated with subclinical atherosclerosis via chronic activation of inflammatory pathways, or direct endothelial injury.…
Abstract Number: 2222 • 2019 ACR/ARP Annual Meeting
Bone Health: An Independent Predictor of Coronary Artery Disease
Lilian Bizzocchi¹, Maria Salgado ¹, Bhavin Chokshi ¹, Navneet Kaur ¹, Oscar Mena ¹ and Michal Packman ², ¹Jacobi Medical Center, Bronx, NY, ²North Central Bronx Hospital, Bronx, NY
Background/Purpose: An association between low bone mineral density (BMD) and cardiovascular events has been shown. The calcification process observed in atherosclerosis and bone mineralization have…
Abstract Number: 2692 • 2019 ACR/ARP Annual Meeting
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
Pavlos Stamatis¹, Moman Mohammad ¹, Peter Merkel ², Martin Englund ³, Carl Turesson ⁴, David Erlinge ¹ and Aladdin Mohammad ¹, ¹Lund University, Lund, Skane Lan, Sweden, ²University of Pennsylvania, Philadelphia, PA, ³Lund University, Lund, Sweden, ⁴Lund University, Malmö, Sweden
Background/Purpose: The aim of this study was to estimate the incidence rate and prevalence of coronary artery diseases (CAD) in patients with temporal artery positive…
Abstract Number: 230 • 2018 ACR/ARHP Annual Meeting
Increased Prevalence of Coronary Artery Disease in Patients with Chest Pain and Seropositive Rheumatoid Arthritis: An Analysis from a Clinical Computed Tomography-Based Large-Scale Population Cohort
Andreas Bugge Tingaard¹, Annette de Thurah², Ina Trolle Andersen³, Anders Hammerich Riis³, Josephine Therkildsen⁴, Ellen-Margrethe Hauge⁵ and Morten Böttcher⁴, ¹Department of Cardiology, Regional Hospital of Herning, Herning, Denmark, ²Department of Rheumatology,, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark, ³Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, ⁴Cardiology, Regional Hospital of Herning, Herning, Denmark, ⁵Department of Rheumatology, Aarhus University Hospital, Aarhus, Aarhus, Denmark
Background/Purpose: Inflammation seems to play a central role in the development of atherosclerosis and inflammatory diseases seem to promote progression of coronary artery disease (CAD).…
Abstract Number: 2819 • 2018 ACR/ARHP Annual Meeting
Alcohol Consumption and the Risk of Coronary Heart Disease and Mortality in Patients with Rheumatoid Arthritis
Isaac Smith¹, Jie Wei², Yuqing Zhang³, Hyon K. Choi² and Marcy Bolster¹, ¹Massachusetts General Hospital, Boston, MA, ²Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, ³Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA
Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk of premature cardiovascular events and mortality. Prospective general population studies have shown moderate alcohol consumption…
Abstract Number: 1585 • 2017 ACR/ARHP Annual Meeting
Role of Corticosteroids in Subclinical Atherosclerosis in SLE: A Systematic Review and Meta-Analysis
Ehsan Rajabirostami¹, Kam Newman², Sreelakshmi Panginikkod¹, Shahrzad Mohammadiankhansari¹, Nader Mehri³, Roshanak Habibi⁴ and Manish Jain⁵, ¹Internal Medicine, Presence Saint Francis Hospital, Evanston, IL, ²Rheumatology, Eisenhower Medical Center, Rancho Mirage, CA, ³Social Gerontology, Miami University, Oxford, OH, ⁴Presence Saint Francis Hospital, Evanston, IL, ⁵Rheumatology, Presence Saint Francis Hospital, Evanston, IL
Background/Purpose: Atherosclerosis in SLE results from a complex interplay between traditional risk factors, SLE-specific factors, chronic inflammation and multifaceted effects of SLE therapeutics. In particular,…
Abstract Number: 2934 • 2017 ACR/ARHP Annual Meeting
Comparative Analysis of the Macrophage Glycolytic Machinery in Giant Cell Arteritis (GCA) and in Coronary Artery Disease (CAD)
Cornelia M. Weyand¹, Ryu Watanabe², Tsuyoshi Shirai³, Hui Zhang⁴, Gerald Berry⁵ and Jorg Goronzy⁶, ¹Medicine: Immunology and Rheumatology, Stanford University, Stanford, CA, ²Medicine: Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA, ³Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, ⁴Medicine: Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, ⁵Pathology, Stanford University School of Medicine, Stanford, CA, ⁶Medicine/Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA
Background/Purpose: Macrophages are key effector cells in the vessel wall inflammation of the atherosclerotic plaque as well as in the intramural infiltrates of giant cell…
Abstract Number: 723 • 2017 ACR/ARHP Annual Meeting
Incidence and Variability of Cardiovascular Risk Factors in Female Lupus Patients: A 3-Year Follow-up
Carolinne Monção¹, Leticia Martins¹, Marcela Penteado¹, Rodrigo Reis², Fabiana Miranda Moura dos Santos³, CRISTINA COSTA LANNA³, Antônio Luiz Ribeiro⁴ and Rosa Weiss Telles⁴, ¹Hospital das Clinicas, Universidade Federal of Minas Gerais, Belo Horizonte, Brazil, ²Universidade Federal of Minas Gerais, Belo Horizonte, Brazil, ³Medical School, Universidade Federal of Minas Gerais, Brazil, Belo Horizonte, Brazil, ⁴Medical School, Universidade Federal of Minas Gerais, Belo Horizonte, Brazil
Background/Purpose: To evaluate the incidence and variability of traditional coronary artery disease (CAD) risk factors in a cohort of systemic lupus erythematosus (SLE) patients. Methods:…
Abstract Number: 1125 • 2017 ACR/ARHP Annual Meeting
Factors Associated with Acute Gouty Arthritis in Patients Hospitalized with Acute Coronary Syndromes and Congestive Heart Failure
Gabriela Montes-Rivera¹, Carla F Gamarra-Hilburn², Lorena González-Sepúlveda³ and Luis M. Vilá⁴, ¹Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, ²Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, ³Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, ⁴Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
Background/Purpose: Hyperuricemia and untreated gout appears to be independent prognostic markers for poor all-cause and coronary heart disease mortality in patients with recent acute myocardial…
Abstract Number: 201 • 2016 ACR/ARHP Annual Meeting
Allopurinol Reduces the Risk of Myocardial Infarction (MI) in the Elderly: A Study of Medicare Claims
Jasvinder A. Singh¹ and Shaohua Yu², ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: To assess whether allopurinol use reduces the risk of myocardial infarction (MI) in the elderly. Methods: We used the 2006-2012 5% random sample of…
Abstract Number: 1179 • 2016 ACR/ARHP Annual Meeting
The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
Nuria Lozano-Rivas¹, Carlos Marras Fernandez-Cid², Francisco Jose Pastor Perez³, Pedro Flores-Blanco⁴, Miriam Gomez-Molina⁴, Alberto Bermudez⁵, Luis Francisco Linares², Javier Martinez Ferrin², Francisco Andrés Martinez-Angosto¹, Pablo Mesa del Castillo² and Sergio Manzano-Fernandez⁴, ¹Rheumatology, Hospital Virgen de la Arrixaca, murcia, Spain, ²Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, ³Cardiology, Hospital Virgen de la Arrixaca, Murcia, Spain, ⁴Cardiology, Hospital Virgen de la Arrixaca, murcia, Spain, ⁵Hospital Virgen de la Arrixaca, Molina de Segura (Mu, Spain
Background/Purpose: Patients with autoimmune diseases (AID) have a high burden of cardiovascular disease leading to premature morbidity and mortality. But it is unclear if it…
Abstract Number: 1716 • 2016 ACR/ARHP Annual Meeting
Higher Frequency and Severity of Coronary Plaques on Coronary CT Angiography in Psoriatic Arthritis Patients without Symptoms of Coronary Artery Disease Compared to Controls
Agnes Szentpetery¹, Darragh Brady², Gerard Healy², Ciaran Redmond², Hannah Fleming², John Duignan², Muhammad Haroon¹, Jonathan Dodd² and Oliver FitzGerald³, ¹St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, ²St. Vincent's University Hospital, Department of Radiology, Dublin, Ireland, ³St. Vincent's University Hospital, Department of Rheumatology. UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
Background/Purpose: Patients with psoriasis (PsO) and psoriatic arthritis (PsA) have an increased prevalence of cardiovascular (CV) risk factors, metabolic syndrome (Metsy), and higher risk…
Abstract Number: 2774 • 2016 ACR/ARHP Annual Meeting
Framingham Risk Score Discriminates Coronary Atherosclerosis in Psoriatic Arthritis Patient Better Than Other Cardiovascular Scores Do
Ho Man LAM¹, Jiayun Shen², Qing SHANG³, Tsz Ho CHENG¹, Edmund LI¹, Ka Tat WONG⁴ and Lai-Shan TAM⁵, ¹Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, ³Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁴Prince of Wales Hospital, Hong Kong, Hong Kong, ⁵Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
Background/Purpose: Patients with psoriatic arthritis (PsA) are associated with higher cardiovascular (CV) risks. The efficacy of established CV risk scores for predicting CV risks in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].